Search Results 1011-1020 of 18305 for Hepatitis C

  1. News - Ronald C. Petersen, M.D., Ph.D. - Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  2. Genotype Optimal Regimens 1 GLE/PIB 8 wks a-TE with PEG/RBV, no cirrhosis 8 wks b-Cirrhosis and TE with non-NS5A DAA 12 wks c-ES

    GLE/PIB 8 wks a-TE with PEG/RBV, no cirrhosis 8 wks b-Cirrhosis and TE with non-NS5A DAA 12 wks c-ESRD 12 wks d-Post-LT without cirrhosis and KT 12 wks.

  3. A Study to assess the Safety of NRL-1 for the Treatment of People with Epilepsy - Mayo Clinic

    Positive blood screen for Human immunodeficiency virus (HIV), Hepatitis B surface antigen (HbSAg), Hepatitis C, or a positive urine screen for alcohol, drugs of ...

  4. Surgery - Doctors - Mayo Clinic

    Hepatitis C, Hepatitis B, Portal hypertension, Hepatocellular carcinoma, Hepatic encephalopathy. Pagination Doctor search. PrevPrevious Page · Go to page 3636 ...

  5. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    Positive serology for hepatitis C (HC) defined as a positive test for HCAb and confirmed by HC RIBA or hepatitis C virus (HCV) RNA viral load; Screening ...

  6. Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - Mayo Clinic

    Patients known to be HIV positive, hepatitis B positive, or hepatitis C positive; Known autoimmune disease or presence of autoimmune phenomena. Evidence of ...

  7. The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

    Active hepatitis B or C established with positive hepatitis B serology (hepatitis B surface antigen and core antigen) and/or positive hepatitis C PCR ...

  8. Publications - Janhavi Athale, M.D. - Mayo Clinic

    ... C, Brunet J, Carmona-Garcia M, Lambertini M ... Hepatitis and Vasodilatory Shock due to an ... Gutierrez C, Brown ART, May HP, Beitinjaneh A ...

  9. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

    Positive hepatitis B (hepatitis B surface antigen and antibody) and/or hepatitis C (hepatitis C antibody test) as indicated by serologies conducted =< 3 ...

  10. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

    Patient must be tested for hepatitis C within 28 days prior to randomization. Patient must not have active hepatitis C virus (HCV) infection. Active HCV is ...